Telmisartan Attenuates Diabetic Nephropathy by Suppressing Oxidative Stress in db/db Mice
Authors:
- Daisuke OgawaDODaisuke Ogawa
- Jun WadaJWJun Wada
- Hiromi TachibanaHTHiromi Tachibana
- Ryo KoderaRKRyo Kodera
- Jun EguchiJEJun Eguchi
- Atsuko NakatsukaANAtsuko Nakatsuka
- Naoto TeramiNTNaoto Terami
- Kenichi ShikataKSKenichi Shikata
- Hirofumi MakinoHMHirofumi Makino
- 10 January 2013
- journal article
- Published by S. Karger AG in Nephron Experimental Nephrology
- Vol. 121 (3-4) , e97-e108
Abstract
Background/Aims: Telmisartan, an angiotensin II type 1 receptor blocker, is widely used to treat hypertension and kidney diseases, including diabetic nephropathy, because of its renoprotective effects. However, the mechanism by which telmisartan prevents proteinuria and renal dysfunction in diabetic nephropathy is still unclear. In this study, we examined the effects of telmisartan against diabetic nephropathy in db/db mice. Methods: Telmisartan was administered at a dose of 5 mg/kg/day for 3 weeks to db/db (diabetic) and db/m (control) mice. Urinary albumin excretion, renal histology, and the gene expression of oxidative stress and inflammatory markers in renal tissue were determined. To evaluate the effects of telmisartan on reactive oxygen species (ROS) production, superoxide was detected by dihydroethidium (DHE) staining in vivo and in vitro. Results: Telmisartan reduced albuminuria, mesangial matrix expansion, macrophage infiltration, and the expression of ROS markers (NADPH oxidase 4- and 8-hydroxydeoxyguanosine) and inflammatory cytokines (monocyte chemoattractant protein-1, osteopontin, and transforming growth factor-β) in the kidney. DHE staining showed that telmisartan decreased ROS generation in the kidney and in cultured mesangial and proximal tubular epithelial cells. Conclusions: Taken together, these findings indicate that telmisartan protects against diabetic nephropathy by reducing diabetes-induced oxidative stress.Keywords
This publication has 32 references indexed in Scilit:
- Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic NephropathyJournal of the American Society of Nephrology, 2012
- Toward a More Complete (and Less Controversial) Understanding of Energy Expenditure and Its Role in Obesity PathogenesisDiabetes, 2011
- The Effect of Obesity on Chronic Kidney DiseaseJournal of Renal Nutrition, 2011
- Reactive Oxygen Species Promote Caspase-12 Expression and Tubular Apoptosis in Diabetic NephropathyJournal of the American Society of Nephrology, 2010
- Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicityPharmacological Research, 2009
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Rap1b GTPase Ameliorates Glucose-Induced Mitochondrial DysfunctionJournal of the American Society of Nephrology, 2008
- Telmisartan Prevents Obesity and Increases the Expression of Uncoupling Protein 1 in Diet-Induced Obese MiceHypertension, 2006
- Telmisartan But Not Valsartan Increases Caloric Expenditure and Protects Against Weight Gain and Hepatic SteatosisHypertension, 2006
- Transforming Growth Factor-β1 Induces Vascular Endothelial Growth Factor Expression in Murine Proximal Tubular Epithelial CellsNephron Experimental Nephrology, 2003